AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-1.41%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.66B
AUM Growth
+$1.66B
(+3.2%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
9.68%
Top 10 Holdings %
Top 10 Hldgs %
82.06%
Holding
92
New
14
Increased
11
Reduced
6
Closed
14
Top Buys
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$136M |
| 2 |
MetLife
MET
|
$21.6M |
| 3 |
Dollar General
DG
|
$14.1M |
| 4 |
American International
AIG
|
$14M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
$13.8M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$29.9M |
| 2 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$23.8M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$15.9M |
| 4 |
Alibaba
BABA
|
$13M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$11.2M |
Sector Composition
| 1 | Consumer Discretionary | 49.16% |
| 2 | Healthcare | 36.88% |
| 3 | Financials | 4.92% |
| 4 | Communication Services | 2.14% |
| 5 | Industrials | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $731M | 25.67% | 29,443,300 | – | – |
|
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $366M | 12.86% | 402,625,866 +149,253,731 | +59% | +$136M |
|
|
3
Alibaba
BABA
$322B
| $49.4M | 1.73% | 475,000 -125,000 | -21% | -$13M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $43.4M | 1.52% | 480,000 -70,000 | -13% | -$6.33M |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $38.8M | 1.36% | 400,000 +100,000 | +33% | +$9.7M |
|
6
Incyte
INCY
$16.5B
| $30M | 1.05% | 410,000 -30,000 | -7% | -$2.19M |
|
|
PCYC
7
DELISTED
PHARMACYCLICS INC
PCYC
| $27.5M | 0.97% | 225,000 | – | – |
|
8
Nektar Therapeutics
NKTR
$568M
| $25.6M | 0.9% | 1,650,000 | – | – |
|
|
BLUE
9
DELISTED
bluebird bio
BLUE
| $25.2M | 0.89% | 275,000 +25,000 | +10% | +$2.29M |
|
10
Ionis Pharmaceuticals
IONS
$6.79B
| $25M | 0.88% | 405,000 -50,000 | -11% | -$3.09M |
|
|
11
MetLife
MET
$54.1B
| $21.6M | 0.76% | +400,000 | New | +$21.6M |
|
|
KITE
12
DELISTED
Kite Pharma, Inc.
KITE
| $20.2M | 0.71% | 350,000 +140,000 | +67% | +$8.07M |
|
|
13
American International
AIG
$45.1B
| $19.6M | 0.69% | 350,000 +250,000 | +250% | +$14M |
|
14
Aptiv
APTV
$17.3B
| $16.4M | 0.57% | 225,000 +25,000 | +13% | +$1.82M |
|
15
Mastercard
MA
$538B
| $15.1M | 0.53% | 175,000 | – | – |
|
|
ARRY
16
DELISTED
Array Biopharma Inc
ARRY
| $14.2M | 0.5% | 3,000,000 | – | – |
|
|
17
Dollar General
DG
$23.9B
| $14.1M | 0.5% | +200,000 | New | +$14.1M |
|
18
General Motors
GM
$55.8B
| $14M | 0.49% | 400,000 +100,000 | +33% | +$3.49M |
|
|
LNKD
19
DELISTED
LinkedIn Corporation
LNKD
| $13.8M | 0.48% | +60,000 | New | +$13.8M |
|
20
Morgan Stanley
MS
$240B
| $13.6M | 0.48% | +350,000 | New | +$13.6M |
|
21
Alphabet (Google) Class C
GOOG
$2.58T
| $13.2M | 0.46% | +25,000 | New | +$13.2M |
|
22
Occidental Petroleum
OXY
$46.9B
| $12.1M | 0.42% | +150,000 | New | +$12.1M |
|
|
ACOR
23
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $10.2M | 0.36% | 250,000 | – | – |
|
|
24
Agios Pharmaceuticals
AGIO
$2.19B
| $10.1M | 0.35% | 90,000 -100,000 | -53% | -$11.2M |
|
25
Aramark
ARMK
$10.3B
| $9.35M | 0.33% | +300,000 | New | +$9.35M |
|